Home > Books > Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions
Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions
View PDF

Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions

Publication Year: 2008
Edition: 1st
Authors/Editor: Small
Publisher: Springer Publishing Company
ISBN: 978-1-933-86434-1
Doody's Star Rating®:  Score: 75
  • Description
  • Details

Biologically targeted agents promise to be the next significant breakthrough in cancer therapy. Written by leading experts in the field, Combining Targeted Biological Agents with Radiotherapy is a comprehensive evaluation of the entire field.

Radiotherapy plays an integral role in cancer treatment. Approximately 60% of cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agents with radiotherapy is the latest cutting-edge extension in cancer therapy for radiation oncologists.

Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions is an overview of the current state of clinical and pre-clinical research in combining radiotherapy with targeted biological agents to fight cancer. The text provides a general overview of targeted agents, reviews the current clinical trials, and includes a look at the future of this state-of-the-art practice

The book begins with a general overview of the topic, including an introduction to the subject; the basic science rationale behind the two most important current targeted agents: epidermal growth factor (EGFR) receptors and vascular epithelial growth factor (VEGF) receptors; the dermatologic manifestations of targeted agents; and an introduction to radioimmunotherapy a treatment that has the ability to combine targeted agents directly with radiotherapy. The second half of the book focuses on specific disease sites, including malignant gliomas, head and neck, lung, pancreatic, cervical, and endometrial cancers.

  • Platform:
    Ovid
  • Publisher: Springer Publishing Company
  • Product Type: Book
  • Author/Editor: Small
  • ISBN: 978-1-933-86434-1
  • Specialty:
    Hematology
    Oncology
    Radiology
  • Language: English
  • Edition: 1st
  • Pages: 226
  • Illustrations: 0
  • Year: 2008
  • Doody's Star Rating®:  Score: 75

Free Instant Access
This Month

JOTM
Biomedical Research Grants—UberResearch NEW! UberResearch is a searchable database of awarded research funding that includes more than 600,000 indexed records. And now it's available on the Ovid® platform!
JOTM
The Philosopher's Index The Philosopher's Index is a bibliographic database with informative author-written abstracts covering scholarly research in the fifteen fields of philosophy, published in journals and books since 1940.
JOTM
Evidence-Based Practice Evidence-Based Practice is a quarterly journal focused on topics relevant to the daily practice of family medicine and includes content addressing timely and pertinent questions related to patient care.
JOTM
Stroke An official journal of the American Heart Association, Stroke publishes reports of clinical and basic investigation of any aspect of the cerebral circulation and its diseases from many disciplines.

Noteworthy

Doody's Featured Books
Shields' General Thoracic Surgery, 8th Edition
Your #1 resource for comprehensive coverage of both open and endoscopic surgical techniques, with commentary from more than 150 global experts in the field.

The Washington Manual of Echocardiography, 2nd Edition
Essential information you need to successfully perform and read echocardiograms, as well as to identify valvular heart disease, cardiac myopathies, and congenital anomalies.